The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies

Anti-programmed cell death protein 1 (PD-1) monoclonal antibody therapy is becoming a standard treatment for advanced melanoma that produces durable responses and prolonged survival, but the prognosis of patients with liver metastases is still unsatisfactory. Here, we analyzed five clinical studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuan, Ji, Qing, Yan, Xieqiao, Lian, Bin, Si, Lu, Chi, Zhihong, Sheng, Xinan, Kong, Yan, Mao, Lili, Bai, Xue, Tang, Bixia, Li, Siming, Zhou, Li, Cui, Chuanliang, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552942/
https://www.ncbi.nlm.nih.gov/pubmed/33117684
http://dx.doi.org/10.3389/fonc.2020.546604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552942/
https://www.ncbi.nlm.nih.gov/pubmed/33117684
http://dx.doi.org/10.3389/fonc.2020.546604

Ejemplares similares